Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Medicine
Volume 2009, Article ID 785047, 4 pages
Case Report

Abnormal 18F-FDG Uptake Detected with Positron Emission Tomography in a Patient with Breast Cancer: A Case of Sarcoidosis and Review of the Literature

1Department of Medical Oncology, GATA (Gulhane) Faculty of Medicine, Etlik, 06018 Ankara, Turkey
2Department of Nuclear Medicine, GATA (Gulhane) Faculty of Medicine, Etlik, 06018 Ankara, Turkey

Received 27 January 2009; Accepted 10 August 2009

Academic Editor: Johny Verschakelen

Copyright © 2009 Selmin Ataergin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. P. Baughman and E. E. Lower, “Disorders of the immune system, connective tissue, and joints, sarcoidosis,” in Harrison's Principle of Internal Medicine, A. S. Fauci, E. Braunwald, and D. L. Kasper, Eds., pp. 2135–2142, McGraw-Hill, New York, NY, USA, 17th edition, 2008. View at Google Scholar
  2. J. P. Battesti, J. Turiaf, J. M. Hincky, and P. Dournovo, “Loco-regional sarcoid reaction. Sarcoidosis and malignant tumors,” Nouv Presse Med., vol. 6, no. 14, pp. 1213–1215, 1977. View at Google Scholar
  3. K. F. Hübner, E. Buonocore, H. R. Gould et al., “Differentiating benign from malignant lung lesions using “quantitative” parameters of FDG PET images,” Clinical Nuclear Medicine, vol. 21, no. 12, pp. 941–949, 1996. View at Publisher · View at Google Scholar
  4. L. Kostakoglu, H. Agress Jr., and S. J. Goldsmith, “Clinical role of FDG PET in evaluation of cancer patients,” Radiographics, vol. 23, no. 2, pp. 315–340, 2003. View at Google Scholar
  5. S. B. Knight, D. Delbeke, J. R. Stewart, and M. P. Sandler, “Evaluation of pulmonary lesions with FDG-PET: comparison of findings in patients with and without a history of prior malignancy,” Chest, vol. 109, no. 4, pp. 982–988, 1996. View at Google Scholar
  6. N. A. Dewan, N. C. Gupta, L. S. Redepenning, J. J. Phalen, and M. P. Frick, “Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules: potential role in evaluation and management,” Chest, vol. 104, no. 4, pp. 997–1002, 1993. View at Google Scholar
  7. S. S. Gambhir, J. Czernin, J. Schwimmer, D. H. S. Silverman, R. E. Coleman, and M. E. Phelps, “A tabulated summary of the FDG PET literature,” Journal of Nuclear Medicine, vol. 42, no. 5, supplement, pp. 1S–93S, 2001. View at Google Scholar
  8. K. Takanami, T. Kaneta, T. Yamada et al., “FDG PET for esophageal cancer complicated by sarcoidosis mimicking mediastinal and hilar lymph node metastases: two case reports,” Clinical Nuclear Medicine, vol. 33, no. 4, pp. 258–261, 2008. View at Publisher · View at Google Scholar
  9. Y.-J. Li, Y. Zhang, S. Gao, and R.-J. Bai, “Cervical and axillary lymph node sarcoidosis misdiagnosed as lymphoma on F-18 FDG PET-CT,” Clinical Nuclear Medicine, vol. 32, no. 3, pp. 262–264, 2007. View at Publisher · View at Google Scholar
  10. L. Kunstmann, B. Bständig, F. Brucker-Davis, J. Mouroux, P. Rigot, and P. Fenichel, “Malignant struma ovarii: false positive PET image for suspected metastasis due to sarcoidosis,” Annales d'Endocrinologie, vol. 68, no. 1, pp. 51–54, 2007. View at Publisher · View at Google Scholar
  11. J. Maeda, M. Ohta, H. Hirabayashi, and H. Matsuda, “False positive accumulation in 18F fluorodeoxyglucose positron emission tomography scan due to sarcoid reaction following induction chemotherapy for lung cancer,” Japanese Journal of Thoracic and Cardiovascular Surgery, vol. 53, no. 4, pp. 196–198, 2005. View at Google Scholar
  12. E. de Hemricourt, K. De Boeck, F. Hilte et al., “Sarcoidosis and sarcoid-like reaction following Hodgkin's disease: report of two cases,” Molecular Imaging and Biology, vol. 5, no. 1, pp. 15–19, 2003. View at Publisher · View at Google Scholar
  13. F. M. Muggia and P. S. Conti, “Seminoma and sarcoidosis: a cause for false positive mediastinal uptake in PET?” Annals of Oncology, vol. 9, no. 8, p. 924, 1998. View at Google Scholar
  14. S. M. B. Bakheet, J. Powe, A. Ezzat, and A. Rostom, “F-18-FDG uptake in tuberculosis,” Clinical Nuclear Medicine, vol. 23, no. 11, pp. 739–742, 1998. View at Publisher · View at Google Scholar
  15. P. C. Amrein, S. M. Larson, and H. N. Wagner Jr., “A rapid automated system for measurement of antibody titers,” Journal of Nuclear Medicine, vol. 15, no. 12, pp. 1145–1148, 1974. View at Google Scholar
  16. R. Kubota, S. Yamada, K. Kubota, K. Ishiwata, N. Tamahashi, and T. Ido, “Intratumoral distribution of fluorine-18-fluorodeoxyglucose in vivo: high accumulation in macrophages and granulation tissues studied by microautoradiography,” Journal of Nuclear Medicine, vol. 33, no. 11, pp. 1972–1980, 1992. View at Google Scholar
  17. L. H. Brudin, S.-O. Valind, C. G. Rhodes et al., “Fluorine-18 deoxyglucose uptake in sarcoidosis measured with positron emission tomography,” European Journal of Nuclear Medicine, vol. 21, no. 4, pp. 297–305, 1994. View at Google Scholar
  18. G. J. R. Cook, E. A. Wegner, and I. Fogelman, “Pitfalls and artifacts in 18FDG PET and PET/CT oncologic imaging,” Seminars in Nuclear Medicine, vol. 34, no. 2, pp. 122–133, 2004. View at Publisher · View at Google Scholar
  19. P. D. Shreve, Y. Anzai, and R. L. Wahl, “Pitfalls in oncologic diagnosis with FDG PET imaging: physiologic and benign variants,” RadioGraphics, vol. 19, no. 1, pp. 61–77, 1999. View at Google Scholar
  20. P. L. Jager, W. Vaalburg, J. Pruim, E. G. E. de Vries, K.-J. Langen, and D. A. Piers, “Radiolabeled amino acids: basic aspects and clinical applications in oncology,” Journal of Nuclear Medicine, vol. 42, no. 3, pp. 432–445, 2001. View at Google Scholar
  21. R. M. Pieterman, T. H. Que, P. H. Elsinga et al., “Comparison of 11C-choline and 18F-FDG PET in primary diagnosis and staging of patients with thoracic cancer,” Journal of Nuclear Medicine, vol. 43, no. 2, pp. 167–172, 2002. View at Google Scholar